drugset
drugset / Trial / NCT03920319

Bupropion and Cigarette-Related Cues in Smokers

NCT03920319 ↗

Phase 1 Completed 34 enrolled University of California, Los Angeles
RandomizedParallel-groupDouble-blindBasic science

Summary

Randomized, double-blind, before-after controlled trial to assess changes in regional brain activation in response to cigarette-related cues from before to after treatment with bupropion (vs placebo).

Timeline

Start
2004-01-01
Primary completion
2005-12-31
Completion
2005-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 150 mg —

Indications

nicotine dependence